The customer focus of our new site mirrors our commitment to innovation and efficiency in providing high-quality gene synthesis
Menlo Park, Calif. (PRWEB) October 17, 2008
DNA2.0, the leading synthetic genomics company, announced today a significant redesign of its web site, providing customers with an enhanced experience and demonstrating the company's expansion. The redesign of the site introduced a fresh, appealing new interface, a customer-friendly site navigation, a database of published synthetic gene applications and a revamped Bioinformatics Toolbox that provides visitors with a powerful resource for analyzing DNA and protein sequences.
"The customer focus of our new site mirrors our commitment to innovation and efficiency in providing high-quality gene synthesis," said Dr. Claes Gustafsson, vice president of sales and marketing for DNA2.0. "DNA2.0 is dedicated to being a resource and research partner for the scientific community. By providing an easy-to-use interface and strengthening our Bioinformatics Toolbox, we are renewing our emphasis on customer service."
DNA2.0's Bioinformatics Toolbox:
Already hailed by Genetic Engineering News as "Best of the Web," DNA2.0's Bioinformatics Toolbox provides tools for generating, formatting and analyzing DNA and protein sequences. With an extensive rage of tools designed for such functions as format conversion, sequence analysis, and sequence figures, the Bioinformatics Toolbox puts all the technology and expertise needed for gene design at the fingertips of the user. The Bioinformatics Toolbox is now easier to use than ever, with convenient pop-out boxes for each tool. For more advanced features, users will want to download the integrated DNA2.0 Gene Designer software suite, available free at http://www.DNA20.com.
DNA2.0 has provided genes to thousands of customers, for whom it has synthesized many millions of base pairs. It is by far the most published synthetic vendor, providing expert support to and collaboration with scientists in academia, government and industry. DNA2.0 guarantees researchers high quality synthetic genes, delivered on time, every time.
Founded in early 2003, DNA2.0 is the leading synthetic genomics company. It is the largest US provider of synthetic genes, with a global customer base comprised of academia, government and the pharmaceutical, chemical, agricultural and biotechnology industries. Using proprietary technologies, DNA2.0 exploits the synergy between highly efficient gene synthesis process and new protein optimization technologies. The tools and applications brought to market by DNA2.0 are transforming biology into an engineering discipline. The company is privately held and is headquartered in Menlo Park, Calif. For more information, please visit http://www.DNA20.com.